http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0307816-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec04824f5593b223d90296d15a16779e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2003-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8c31f38ab2d49fdcb094061b50e825a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea3d5486397d6e59eab160fd92637f5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42035c4ba9cd05e4c5420d6a3ca95daf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9c473231e67f691f751228a9a24a53
publicationDate 2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0307816-B1
titleOfInvention ORAL PHARMACEUTICAL COMPOSITION SUITABLE AS A LIQUID LOAD COMPOSITION FOR A SOFT CAPSULE DOSAGE FORM
abstract "Oral pharmaceutical composition for vinorelbine-containing soft capsules and method of treatment". The invention described herein relates to a vinorelbine-containing pharmaceutical composition as an active ingredient that is suitable for encapsulation in soft capsules. The suitable oral liquid pharmaceutical composition for the liquid filler composition for a soft capsule dosage form comprises: vinorelbine or a pharmaceutically acceptable salt thereof; ethanol; Water; glycerol; and polyethylene glycol. In the preferred embodiment, the vinorelbine tartrate salt form is employed in the composition. The invention also provides for a method of treating cancer comprising orally administering to a patient in need of such treatment a soft capsule comprising the pharmaceutical composition of the invention.
priorityDate 2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422966313
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44424639
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37888
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1441535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540048
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40904
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21780850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070748
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1441535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39130
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497

Total number of triples: 47.